Three hundred thirty eight @entity1 with @entity189 in the middle and lower thirds of the esophagus received Ivor-Lewis esophagogastrectomy (separate laparotomy and right thoracotomy incisions) from February 1986 to June 1992. The total resectability was 95.2%. Lymph node @entity3 were found in 136 cases (40.2%). @entity260 developed in 10.3% of the @entity1 . No anastomotic leakage, nor postoperative (within 30 days) @entity204 and @entity204 occurred. Major @entity358 occurred in 28.6% of the @entity1 . The overall 1-, 3- and 5-year survival rate was 88.5% (231/261), 63.1% (125/198) and 48.4% (60/124), respectively. The five-year survival rate was 64.1% (41/64) in @entity1 with negative lymph nodes as compared to 31.7% (19/60) with positive nodes. The superiority of this technique was a significant improvement of the 5-year survival rate. This was due to better exposure of the operation field which made thorough dissection of lymph nodes possible, especially those along the right recurrent laryngeal nerve. Better operative exposure also provided chances for redical resection with less interference from the aortic arch. It made @entity254 easier to perform so that stenosis and leakage were less likely to occur. Ivor-Lewis esophagogastrectomy is a superior surgical procedure of choice for the treatment of @entity5 at the lower and middle thirds of the esophagus.

[Results on Ivor-Lewis esophagogastrectomy for 338 cases of XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity254 :: ('MESH:C563598', 'Disease') :: ['anastomosis'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity260 :: ('MESH:D011183', 'Disease') :: ['Postoperative complications'] @entity358 :: ('MESH:D008171', 'Disease') :: ['pulmonary complications'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity204 :: ('MESH:D003643', 'Disease') :: ['hospital death', 'death']
@entity189 :: (MESH:D002277,Disease) :: ['carcinoma of esophagus']
